Vantage Consulting Group Inc Eli Lilly & CO Transaction History

Vantage Consulting Group Inc

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$724.87 - $909.04 $31,894 - $39,997	-44 Reduced 14.1%	268 $242,000
Q1 2024 May 15, 2024	SELL	$592.2 - $792.28 $46,191 - $61,797	-78 Reduced 20.0%	312 $242,000
Q4 2023 Feb 14, 2024	SELL	$525.19 - $619.13 $3,151 - $3,714	-6 Reduced 1.52%	390 $227,000
Q3 2023 Nov 14, 2023	SELL	$434.7 - $599.3 $51,729 - $71,316	-119 Reduced 23.11%	396 $212,000
Q2 2023 Aug 11, 2023	SELL	$350.74 - $468.98 $86,632 - $115,838	-247 Reduced 32.41%	515 $241,000
Q1 2023 May 10, 2023	BUY	$310.63 - $364.82 $28,267 - $33,198	91 Added 13.56%	762 $261,000
Q4 2022 Feb 13, 2023	SELL	$321.55 - $374.67 $45,338 - $52,828	-141 Reduced 17.36%	671 $245,000
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $1,778 - $2,027	6 Added 0.74%	812 $263,000
Q2 2022 Aug 09, 2022	SELL	$278.73 - $327.27 $15,887 - $18,654	-57 Reduced 6.6%	806 $261,000
Q1 2022 May 16, 2022	SELL	$234.69 - $291.66 $47,172 - $58,623	-201 Reduced 18.89%	863 $247,000
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $11,242 - $13,952	50 Added 4.93%	1,064 $294,000
Q3 2021 Nov 10, 2021	BUY	$221.6 - $272.71 $1,329 - $1,636	6 Added 0.6%	1,014 $234,000
Q2 2021 Aug 11, 2021	BUY	$180.55 - $233.54 $181,994 - $235,408	1,008 New	1,008 $231,000
Q1 2021 May 14, 2021	SELL	$164.32 - $212.72 $75,258 - $97,425	-458 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$130.46 - $172.63 $59,750 - $79,064	458 New	458 $77,000

4,004

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $711B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Vantage Consulting Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vantage Consulting Group Inc with notifications on news.